because of the potential for pa and napa toxicity in patients with renal insufficiency , especially in patients with changing renal function due to acute renal failure , it is recommended that the use of pa be curtailed in this population and that another substitute antiarrhythmic agent be used .
C0033216
pa
C0003195
antiarrhythmic agent